Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system
- PMID: 7406938
- DOI: 10.1002/art.1780230802
Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system
Abstract
Precipitating antibodies occurring in 26 "pure" polymyositis (PM) patients and 22 "pure" dermatomyositis (DM) patients were studied by double immunodiffusion using calf thymus nuclear extract and whole calf thymus extract. Seventeen of 26 (65%) PM sera and 13 of 22 (59%) DM sera showed positive reactions, and 18, 10, and 2 sera exhibited 1, 2, and 3 precipitin lines, respectively. Common specificities were established by immunodiffusion for the 11 PM and 6 DM sera with strong precipitin lines. These were classed into three groups of shared specificity and six reactions specific for individual sera. These 9 calf thymus antigens were shown to be different from the known soluble tissue antigens Sm, nuclear RNP, Ro, and La. A 600-fold purification of the most frequently appearing system designated Jo-1 was achieved and its clinical specificity for patients with PM syndromes was established.
Similar articles
-
Antinuclear antibody with distinct specificity for polymyositis.J Clin Invest. 1977 Jan;59(1):176-8. doi: 10.1172/JCI108616. J Clin Invest. 1977. PMID: 318657 Free PMC article.
-
The association between Mi-2 antibodies and dermatomyositis.Arthritis Rheum. 1985 Jul;28(7):796-803. doi: 10.1002/art.1780280711. Arthritis Rheum. 1985. PMID: 2409985
-
Antibodies to Mi-1 in SLE: relationship to other precipitins and reaction with bovine immunoglobulin.Clin Exp Immunol. 1983 Jul;53(1):76-82. Clin Exp Immunol. 1983. PMID: 6409478 Free PMC article.
-
[Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review].Rev Med Interne. 2010 Aug;31(8):540-4. doi: 10.1016/j.revmed.2010.04.004. Epub 2010 May 26. Rev Med Interne. 2010. PMID: 20510485 Review. French.
-
Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.Rheumatology (Oxford). 2014 Mar;53(3):397-405. doi: 10.1093/rheumatology/ket279. Epub 2013 Aug 22. Rheumatology (Oxford). 2014. PMID: 23970542 Review.
Cited by
-
Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice.J Clin Invest. 1987 Aug;80(2):499-506. doi: 10.1172/JCI113098. J Clin Invest. 1987. PMID: 3038960 Free PMC article.
-
Intractable polymyositis: prolonged remission induced by total body irradiation.J R Soc Med. 1985 Jun;78(6):496-7. doi: 10.1177/014107688507800617. J R Soc Med. 1985. PMID: 3889336 Free PMC article. No abstract available.
-
Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease.J Clin Invest. 1989 Jul;84(1):162-72. doi: 10.1172/JCI114136. J Clin Invest. 1989. PMID: 2661587 Free PMC article.
-
Higher eukaryotic aminoacyl-tRNA synthetases in physiologic and pathologic states.Mol Cell Biochem. 1986 Aug;71(2):107-20. doi: 10.1007/BF00214769. Mol Cell Biochem. 1986. PMID: 3534543 Review.
-
Antisynthetase syndrome presenting as interstitial lung disease: a case report.J Med Case Rep. 2019 Aug 4;13(1):241. doi: 10.1186/s13256-019-2146-0. J Med Case Rep. 2019. PMID: 31376837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials